FDA Drug recall D-0745-2026
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, D…
- FDA Drug
- Class II
- ongoing
- Published 2026-08-12
On 2026-08-12 the FDA classified a Class II recall of Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, D… by Zydus Pharmaceuticals Usa, citing CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0745-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-08-05 |
| Published | 2026-08-12 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zydus Pharmaceuticals Usa |
| Distribution | US |
Product
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.
Reason
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Identifiers
| ndc | 70710-1159-3 |
|---|---|
| ndc | 70710-1159-9 |
| ndc | 70710-1159-1 |
| ndc | 70710-1160-3 |
| ndc | 70710-1160-9 |
| ndc | 70710-1160-1 |
| code_info | Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0745-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.